Intraluminal pH and Goblet Cell Density in Barrett's Esophagus

Journal of Gastrointestinal Surgery

Volumn 16, Issue 3, 2012, Pages 469-474

  Theodorou, Dimitrios ^a   Ayazi, Shahin ^a   DeMeester, Steven R ^a   Zehetner, Joerg ^a   Peyre, Christian G ^a   Grant, Kimberly S ^a   Augustin, Florian ^a   Oh, Daniel S ^a   Lipham, John C ^a   Chandrasoma, Parakrama T ^a   Hagen, Jeffrey A ^a   DeMeester, Tom R ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Barrett's esophagus; Gastroesophageal reflux disease (GERD); Goblet cell; pH gradient

Indexed keywords

EID: 84856737413     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1776-3     Document Type: Article

References (19)

1. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976; 295(9): 476-80.
2. Oberg S, Peters JH, DeMeester TR, et al. Determinants of intestinal metaplasia within the columnar-lined esophagus. Arch Surg. 2000 Jun; 135(6): 651-5; discussion 655-6.
3. Ayazi S, Leers JM, Oezcelik A, et al. Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endosc. 2009 Sep; 23(9): 1968-73.
4. Zaninotto G, DeMeester TR, Schwizer W, et al. The lower esophageal sphincter in health and disease. Am J Surg. 1988; 155(1): 104-111.
5. Ayazi S, Hagen JA, Zehetner J, et al. Day to day discrepancy in bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease. Surg Endosc. 2011; 25(7): 2219-23.
6. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. The American Journal of Gastroenterology 2002; 97(8): 1888-1895.
7. Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol. 2001; 25(9): 1188-93.
8. Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg. 2001 Nov; 136(11): 1267-73.
9. Schweitzer EJ, Bass BL, Batzri S, Harmon JW. Bile acid accumulation by rabbit esophageal mucosa. Digestive Diseases & Sciences 1986; 31(10): 1105-13.
10. Schweitzer EJ, Bass BL, Batzri S, Harmon JW. Esophageal mucosa: a bile acid sink in the rabbit. Surgical Forum 1983; 34: 152-3.
11. Hu Y, Jones C, Gellersen O, Williams VA, et al. Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg. 2007 Jun; 142(6): 540-4; discussion 544-5.
12. Souza RF, Krishnan K, Spechler SJ. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2): G211-8.
13. Oh, DS; DeMeester, SR; Mori, R, et al. Sonic hedgehog gene expression in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2008, 134: A150.
14. Möbius C, Stein HJ, Spiess C, Becker I, et al. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer. Eur J Surg Oncol. 2005 Sep; 31(7): 755-9.
15. Cronin J, McAdam E, Danikas A, et al. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). Am J Gastroenterol. 2011 Jan; 106(1): 46-56.
16. Tselepis C, Morris CD, Wakelin D, et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut. 2003 Feb; 52(2): 174-80.
17. Umansky M, Yasui W, Hallak A, et al. Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus. Oncogene2001; 20: 7987-91.
18. Theisen J, Peters JH, Fein M, et al. The mutagenic potential of duodenoesophageal reflux. Annals of Surgery 2005; 241(1): 63-8.
19. Bernstein H, Bernstein C, Payne CM, et al. Bile acids as carcinogens in human gastrointestinal cancers. Mutation Research 2005; 589(1): 47-65.